3D Printed Drugs Market Share to Hit US$ 57.03 Million, Worldwide, by 2027 – Growth Report by The Insight Partners
According to a new market research study titled “3D Printed Drugs Market Forecast to 2027 – Covid-19 Impact and Global Analysis by Dosage Forms and Technology,” the global 3D printed drugs market is expected to reach US$ 57.03 Mn in 2027 from US$ 28.52 Mn in 2019. The market is estimated to grow at a CAGR of 9.1% during 2020–2027. The report highlights the market trends and the driving factors and restraints to market growth.
Get Sample Copy of this Report at https://www.theinsightpartners.com/sample/TIPRE00010199/
Here are some of the Top Companies Analyzed
- APRECIA PHARMACEUTICALS LLC
- FabRx LTD
- Cycle Pharmaceuticals
- GLAXOSMITHKLINE PLLC
- ASTRAZENECA
- Tvasta
- Merck KGGA
- More
3D printed medicines are growing in popularity due to the increasing acceptance of personalized medicines and increased awareness of 3D printed drugs. According to a PMC study, personalized medicines made up 5% of all new FDA-approved molecular entities in 2005. In 2016, however, they made up more than 25%. A further 42% and 73% respectively of all compounds as well as oncology compounds are capable of functioning as personalized medicines. Moreover, biopharmaceutical companies have nearly doubled their R&D investments in personalized drugs over the past five years, and they are further likely to increase their investment by 33% in the next five years. Biopharmaceutical researchers predict a 69% increase in personalized medicines over the next five-years.
Check Exclusive Discount on this Report at https://www.theinsightpartners.com/discount/TIPRE00010199/
Personalized medicine is a rapidly growing area of medicine that relies upon specific drug delivery. According to a PMC study, personalized medicines made up 5% of new FDA approved molecular entities. In contrast, they made up 25% of FDA approved molecular entities for 2016. A further 42% of all compounds, and 73% of the oncology compounds in pipeline are potential personalized medicines. Moreover, biopharmaceutical companies nearly doubled their R&D investment in personalized drugs over the past five years, and expect to increase their investment by 33% in the next five years. Biopharmaceutical experts predict that there will be a 69% rise in personalized medicines under development in the next five years.
Industries Segments
3D printed drugs Market – By Dosage Form
- Tablets
- Capsules
- Multi Drug Implant
- Nanoparticles
- Solutions
- Other Dosage Formulas
3D printed drugs Market – By Technology
- Inkjet Printing
- Direct Write
- Zip Dose
- Thermal Inkjet Printing
- Fused Deposition Modeling
- Powder Bed Printing
- Stereolithography (SLA).
- Semi Solid Extrusion
Purchase this Report at https://www.theinsightpartners.com/buy/TIPRE00010199/
About us:
The Insight Partner is an industry research company that provides actionable intelligence. Our syndicated and consulting services allow us to assist our clients in obtaining solutions to their research needs. We offer specialized services in areas such as Semiconductor and Electronics and Aerospace and Defense.
Get in touch with us
We are happy to answer any questions you may have about the report, or provide further information.
Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876